AU2001292351A1 - Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof - Google Patents

Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof

Info

Publication number
AU2001292351A1
AU2001292351A1 AU2001292351A AU2001292351A AU2001292351A1 AU 2001292351 A1 AU2001292351 A1 AU 2001292351A1 AU 2001292351 A AU2001292351 A AU 2001292351A AU 2001292351 A AU2001292351 A AU 2001292351A AU 2001292351 A1 AU2001292351 A1 AU 2001292351A1
Authority
AU
Australia
Prior art keywords
remedies
salts
diseases containing
retinal nerve
nerve diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001292351A
Other versions
AU2001292351B2 (en
Inventor
Satoshi Ono
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Priority claimed from PCT/JP2001/008745 external-priority patent/WO2002030420A1/en
Publication of AU2001292351A1 publication Critical patent/AU2001292351A1/en
Application granted granted Critical
Publication of AU2001292351B2 publication Critical patent/AU2001292351B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001292351A 2000-10-10 2001-10-04 Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof Ceased AU2001292351B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-308721 2000-10-10
JP2000308721 2000-10-10
PCT/JP2001/008745 WO2002030420A1 (en) 2000-10-10 2001-10-04 Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof

Publications (2)

Publication Number Publication Date
AU2001292351A1 true AU2001292351A1 (en) 2002-06-27
AU2001292351B2 AU2001292351B2 (en) 2006-02-23

Family

ID=18788985

Family Applications (2)

Application Number Title Priority Date Filing Date
AU9235101A Pending AU9235101A (en) 2000-10-10 2001-10-04 Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof
AU2001292351A Ceased AU2001292351B2 (en) 2000-10-10 2001-10-04 Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU9235101A Pending AU9235101A (en) 2000-10-10 2001-10-04 Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof

Country Status (6)

Country Link
US (1) US20040014777A1 (en)
EP (1) EP1325744A4 (en)
JP (1) JPWO2002030420A1 (en)
AU (2) AU9235101A (en)
CA (1) CA2424585A1 (en)
WO (1) WO2002030420A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ543100A (en) * 2003-04-17 2008-07-31 Toyama Chemical Co Ltd Preventive/remedy for retinal nerve dieases containing alkyl ether derivatives or salts thereof
KR100954545B1 (en) * 2009-03-23 2010-05-06 주식회사 수산에너지 Air-water separating and backfire preventing apparatus, and hydrogen-oxygen mixed gas product apparatus comprising thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US580032A (en) * 1897-04-06 Bicycle-support
US5280032A (en) * 1989-02-14 1994-01-18 Toyama Chemical Co., Ltd. 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same
JP3044055B2 (en) * 1990-08-09 2000-05-22 富山化学工業株式会社 1,2-ethanediol derivatives and salts thereof
DE69525063T2 (en) * 1994-10-25 2002-08-14 Toyama Chemical Co Ltd 1,2-ETHANEDIOL DERIVATIVE OR SALT-CONTAINING POTENTIATOR OF THE ACTIVITY OF THE NERVOUS GROWTH FACTOR
EP0903144A4 (en) * 1996-04-17 2001-10-31 Sumitomo Pharma Remedy for retinal neuropathy
US5980929A (en) * 1998-03-13 1999-11-09 Johns Hopkins University, School Of Medicine Use of a protein tyrosine kinase pathway inhibitor in the treatment of retinal ischmemia or ocular inflammation

Similar Documents

Publication Publication Date Title
ZA200107989B (en) 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof.
AU5732699A (en) Corneal onlay
AU2001284483A1 (en) Remedies for heart failure
AU2001284413A1 (en) Medicinal compositions for preventing or treating heart failure
AU1548001A (en) Ophthalmic aqueous preparation
AU2001264042A1 (en) 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
EP1440691A3 (en) Treatment of neurotic disorders
AU2000279614A1 (en) Remedies for endothelin-induced diseases
AU6827800A (en) Aqueous pharmaceutical composition containing moxifloxacin or salts thereof
WO2001058875A3 (en) Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
HUP0104033A3 (en) 1-benzoyl-tetrahydropyridazine derivatives, process for their preparation, their use and medicaments containing the compounds
AU2000272858A1 (en) Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
AU2001277738A1 (en) Piperidine derivatives and drugs containing these derivatives as the active ingredient
AU2002233220A1 (en) Medicament for preventing or treating tumors caused by human papilloma virus type 18
AU2002224022A1 (en) Preventives or remedies for endoplasmic reticulum stress-associated diseases
HUP0204177A3 (en) N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
MXPA01003761A (en) Remedies for ocular diseases.
AU2002215187A1 (en) S-adenosylmethionine and derivatives thereof for the treatment and prevention ofalzheimer's disease
AU2001292351A1 (en) Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof
AU9235101A (en) Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof
AU1556601A (en) 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient
AU4264096A (en) 3,4-dihydro-2,5,7,8-tetramethyl-benzopyran-6-ol derivatives for use as drugs
AU2001228863A1 (en) Remedies for ophthalmic diseases
AU6473699A (en) Aqueous drug formulation for oral application
AU2001271026A1 (en) Remedies for bone diseases